NOVO NORDISK A/S Toevoegen aan een lijst
|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 877,80 DKK | -1,04% |
|
-5,40% | +25,67% |
Bedrijfswaardering: Novo Nordisk A/S
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 909.347 | 986.612 | 1.674.992 | 2.118.803 | 3.112.331 | 3.932.571 | - | - |
| Variatie | - | 8,5% | 69,77% | 26,5% | 46,89% | 26,35% | - | - |
| Bedrijfswaarde 1 | 898.355 | 984.211 | 1.684.152 | 2.121.013 | 3.109.107 | 3.946.677 | 3.923.505 | 3.891.128 |
| Variatie | - | 9,56% | 71,12% | 25,94% | 46,59% | 26,94% | -0,59% | -0,83% |
| K/w-verhouding | 23,6x | 23,7x | 35,4x | 38,4x | 37,5x | 39,1x | 30,7x | 25,8x |
| PBR-ratio | 15,8x | 15,8x | 24x | 25,6x | 29,4x | 27,4x | 20,3x | 15,8x |
| PEG | - | 2,38x | 2,3x | 2,2x | 0,7x | 1,8x | 1,1x | 1,4x |
| Marktkapitalisatie/omzet | 7,45x | 7,77x | 11,9x | 12x | 13,4x | 13,6x | 11,3x | 9,69x |
| Bedrijfswaarde/omzet | 7,36x | 7,75x | 12x | 12x | 13,4x | 13,6x | 11,2x | 9,59x |
| Bedrijfswaarde/EBITDA | 15,5x | 16,4x | 26x | 25,8x | 27,8x | 27,7x | 22,2x | 18,7x |
| Bedrijfswaarde/EBIT | 17,1x | 18,2x | 28,7x | 28,4x | 30,3x | 30,7x | 24,3x | 20,5x |
| Bedrijfswaarde/FCF | 26,1x | 34,5x | 57,4x | 37x | 45,5x | 53x | 41,6x | 32,9x |
| FCF Yield | 3,83% | 2,9% | 1,74% | 2,7% | 2,2% | 1,89% | 2,4% | 3,04% |
| Dividend per aandeel 2 | 4,175 | 4,55 | 5,2 | 6,2 | 9,4 | 11,4 | 15,03 | 17,6 |
| Rendement | 2,16% | 2,13% | 1,41% | 1,32% | 1,35% | 1,29% | 1,69% | 1,98% |
| WPA 2 | 8,19 | 9,005 | 10,37 | 12,22 | 18,62 | 22,71 | 28,89 | 34,4 |
| Uitkeringspercentage | 51% | 50,5% | 50,1% | 50,7% | 50,5% | 50,2% | 52% | 51,2% |
| Omzet 1 | 122.021 | 126.946 | 140.800 | 176.954 | 232.261 | 290.081 | 348.988 | 405.888 |
| EBITDA 1 | 58.144 | 59.879 | 64.669 | 82.171 | 111.987 | 142.456 | 176.414 | 207.955 |
| EBIT 1 | 52.483 | 54.126 | 58.644 | 74.809 | 102.574 | 128.373 | 161.428 | 189.856 |
| Nettowinst (verlies) 1 | 38.951 | 42.138 | 47.757 | 55.525 | 83.683 | 101.797 | 127.816 | 149.148 |
| Nettoschuld 1 | -10.992 | -2.401 | 9.160 | 2.210 | -3.224 | 14.105 | -9.067 | -41.443 |
| Referentiekoers 2 | 193,32 | 213,32 | 367,50 | 469,00 | 698,10 | 887,00 | 887,00 | 887,00 |
| Aantal aandelen (in duizend) | 4.703.720 | 4.624.923 | 4.557.801 | 4.517.704 | 4.458.288 | 4.433.564 | - | - |
| Datum van publicatie | 05-02-20 | 03-02-21 | 02-02-22 | 01-02-23 | 31-01-24 | - | - | - |
1DKK in Miljoen2DKK
Geschatte gegevens
K/w-verhouding, Gedetailleerde evolutie
Toevoegen aan een lijst 0 geselecteerde | K/w-verhouding | EV/omzet | Beurskap. / EBITDA | Dividendrendement (Y) | Kapi. ($) | |
|---|---|---|---|---|---|---|
| 39.05x | 13.57x | 27.64x | +1.29% | 582 mld. | ||
| 58.57x | 18.14x | 44.08x | +0.57% | 818 mld. | ||
| 21.33x | 4.61x | 13.09x | +2.81% | 401 mld. | ||
| 38.23x | 7.23x | 15.62x | +3.17% | 347 mld. | ||
| 15.39x | 4.9x | 11.21x | +2.66% | 293 mld. | ||
| 15.95x | 3.79x | 9.91x | +3.69% | 254 mld. | ||
| 29.71x | 5.33x | 15.8x | +1.85% | 258 mld. | ||
| 21.22x | 5.02x | 12.71x | +3.22% | 238 mld. | ||
| 49.49x | 6.79x | 11.88x | +2.82% | 175 mld. | ||
| 21.59x | 3.7x | 10.11x | +5.66% | 167 mld. | ||
| Gemiddelde | 31,05x | 7,31x | 17,20x | +2,77% | 353,08 mld. | |
| Gewogen gemiddelde per kap. | 35,67x | 9,59x | 22,50x | +2,22% |
Historische koers/winstverhouding
Evolutie van de historische PBR-ratio
Evolutie bedrijfswaarde/omzet
Historische marktkapitalisatie/EBITDA
Evolutie van de historische prestaties
- Beurs
- Aandelen
- Koers NOVO B
- Totale waarde Novo Nordisk A/S
